This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
PRA Health Launches PSN to Expand in Pediatric Care, Stock Up
by Zacks Equity Research
PRA Health's (PRAH) Center for Pediatric Clinical Development is likely to enhance pediatric clinical testing and design with the latest move.
IQVIA Holdings Rides on Technological Suite Amid Debt Woes
by Zacks Equity Research
IQVIA Holdings (IQV) continues to serve the life sciences industry with the help of advanced analytics, technology solutions and contract research services. However, high debt remains a major concern.
IQVIA (IQV) Down 5.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IQVIA Introduces SaaS Based eConsent Tool for Clinical Trials
by Zacks Equity Research
IQVIA's (IQV) latest eConsent tool is likely to boost the Technology & Analytics Solutions segment.
Business Services Stocks' Earnings on Nov 13: SWCH and GDS
by Zacks Equity Research
The Business Services sector benefits from economic growth. Investors interested in stocks from this sector can watch out for third-quarter 2018 earnings reports of SWCH and GDS.
Business Services Stocks' Q3 Earnings on Nov 1: IT, SRCL, WU
by Zacks Equity Research
The business services sector is currently in good shape. Investors interested in stocks from this sector can watch out for third-quarter 2018 earnings reports of IT, SRCL and WU on Nov 1.
Business Services Stocks' Earnings on Oct 31: ADP, APTV, FISV
by Zacks Equity Research
Investors interested in the business services stocks can watch out for earnings reports of ADP, APTV and FISV on Oct 31.
IQVIA (IQV) Beats Q3 Earnings Estimates, Updates '18 View
by Zacks Equity Research
IQVIA Holdings (IQV) third-quarter 2018 earnings and revenues improve on a year-over-year basis.
IQVIA Holdings (IQV) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
IQVIA (IQV) delivered earnings and revenue surprises of 2.16% and 0.50%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
IQVIA Holdings (IQV) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
IQVIA Holdings' (IQV) third-quarter 2018 earnings are likely to benefit from lower tax rates and operating efficiency.
Here's How IQVIA Will Benefit From Genomics England Allaince
by Zacks Equity Research
IQVIA's (IQV) partnership with Genomics England is expected to boost the Technology & Analytics Solutions segment.
Here's Why Investors Should Retain IQVIA Holdings (IQV) Stock
by Zacks Equity Research
IQVIA Holdings (IQV) looks well poised to benefit from expanding global healthcare system.
IQVIA Holdings (IQV) Inks Technology Deal With Theramex
by Zacks Equity Research
Technology partnership with Theramex is likely to boost IQVIA Holdings' (IQV) presence in Europe, Africa and Asia-Pacific regions.
6 Reasons Why You Should Invest in IQVIA Holdings (IQV) Now
by Zacks Equity Research
IQVIA Holdings (IQV) serves the life sciences industry with the help of advanced analytics, technology solutions and contract research services.
Can The Uptrend Continue for IQVIA Holdings (IQV)?
by Zacks Equity Research
Investors certainly have to be happy with IQVIA Holdings Inc. (IQV) and its short term performance
IQV or SWCH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
IQV vs. SWCH: Which Stock Is the Better Value Option?
IQVIA (IQV) Beats Q2 Earnings Estimates, Raises 2018 View
by Zacks Equity Research
IQVIA's (IQV) strategic investments in innovation bode well for the company.
IQVIA Holdings (IQV) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
IQVIA (IQV) delivered earnings and revenue surprises of 4.03% and 2.53%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
IQVIA Holdings (IQV) Tops Q2 Earnings and Revenues Estimates
by Zacks Equity Research
IQVIA (IQV) has raised its full-year guidance raised for revenue, adjusted EBITDA and adjusted EPS.
ManpowerGroup (MAN) Q2 Earnings Meet Estimates, Revenues Lag
by Zacks Equity Research
ManpowerGroup (MAN) continues to see strong growth in its solutions business, especially in RPO, which witnessed double-digit year-over-year revenues and gross profit growth in the second quarter.
Business Services Q2 Earnings on Jul 24: IQV, TSS & More
by Zacks Equity Research
While we expect IQVIA Holdings and Total System Services to post earnings beat in second-quarter 2018, the reverse is likely to occur for Robert Half, Interpublic and Waste Connections.
Waste Management (WM) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Tax benefits and improved collection and disposal business are expected to drive Waste Management's (WM) second-quarter 2018 results.
S&P Global (SPGI) to Report Q2 Earnings: Is a Beat in Store?
by Zacks Equity Research
Strength across segments and lower U.S tax rates are likely to boost S&P Global's (SPGI) second-quarter 2018 results.
Robert Half International (RHI) Q2 Earnings: What's in Store?
by Zacks Equity Research
Strength across all the segments and lower U.S tax rates are likely to boost Robert Half's (RHI) second-quarter 2018 results.
Robust Top Line, Tax Cut to Up TransUnion (TRU) Q2 Earnings
by Zacks Equity Research
Strength across all the segments and lower U.S tax rates are likely to boost TransUnion's (TRU) second-quarter 2018 results.